Lantern Pharma Inc. Operating Lease, Liability, Noncurrent
Lantern Pharma Inc. (LTRN) had Operating Lease, Liability, Noncurrent of $13.52 thousand as of 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-03-30
- 2025-06-30: Operating Lease, Liability, Noncurrent $13.52K.
- 2025-03-31: Operating Lease, Liability, Noncurrent $33.42K.
- 2024-12-31: Operating Lease, Liability, Noncurrent $52.84K.
- 2024-09-30: Operating Lease, Liability, Noncurrent $93.95K.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2025-06-30 | $13.52K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $33.42K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $52.84K 10-K · filed 2026-03-30 |
| 2024-09-30 | $93.95K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $54.69K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $15.56K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $61.50K 10-K · filed 2025-03-27 |
| 2023-09-30 | $106.52K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $150.71K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $140.63K 10-Q · filed 2023-05-09 |
| 2022-03-31 | $13.30K 10-Q · filed 2022-05-03 |
| 2021-12-31 | $52.89K 10-K · filed 2023-03-20 |
| 2021-09-30 | $92.02K 10-Q · filed 2021-11-01 |
| 2021-06-30 | $130.71K 10-Q · filed 2021-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |